MENU
MTNB
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Matinas Biopharma Holdings (MTNB) Ownership - Who owns Matinas Biopharma Holdings?
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
1545 Route 206 South
Phone
+1 908 484-8805
Employees
32
Web
https://www.matinasbiopharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.11M
P/E Ratio
N/A
Total Cash
6.53M
Projected Growth
N/A
Total Debt
2.53M
Revenue
N/A
Risk (Beta)
2.17
Dividend Yield
N/A
Total Cash/Share
1.17
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MTNB
Capitalization
10.1M
P/E Ratio
N/A
Risk (Beta)
2.17
Dividend Yield
N/A
Total Cash
6.53M
Total Cash/Share
1.17
Total Debt
2.53M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
7.68M
P/B Ratio
1.32
Cash Flow
N/A
Earnings
-3.87
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
4.07
Current Revenue Per Employee
32235.29
Dividends Per Share - Security
N/A
EBITDA
-11.39M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-109.58
Shares Held By Institutions
693K
Shares Outstanding - Current
5.55M
Total Liabilities
3.75M
Total Volume MTD
N/A
Value
1
Gain YTD
256.863
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a manufacturer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
1545 Route 206 South
Phone
+1 908 484-8805
Employees
32
Web
https://www.matinasbiopharma.com